Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Modern Water Plc | MWG | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.45 | 00:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.45 | 2.45 |
| Top Posts |
|---|
Posted at 10/11/2020 16:42 by katsy Hmm I wonder!! Even though MWG will be delisted it will still operate as a private company for which the CEO's will still receive a salary, paid for in DVRG shares. Does that not count is being paid twice for the same role seeing as MWG and DVRG are two of the same. |
Posted at 10/11/2020 08:43 by judijudi My MWG shares are still MWG shares 🤷a |
Posted at 09/11/2020 15:21 by aylesone And so the MWG roller coaster ride continues! I bought at around 11p some years back and also at 0.6p this year. For now I just hold, Que Sera Sera. Absolutely no idea what will happen with DVRG "Quaz", but at least we are still in business with "I think" a better chance of future success than remaining as MWG.Great news on the vaccine though! |
Posted at 06/11/2020 09:06 by monkey puzzle The exchange of DeepVerge shares for MWG shares will create a subsidiary of MWG inside DeepVerge who will own the shares of MWG, as a private company, just like any other subsidiary. The benefit is the enlarged shareholders of DVRG and the assets and subdivisions of MWG will carry on to operate as they are, under the new management and new business model of DVRG. All the tax losses of MWG will be for the benefit of the enlarged Company also. |
Posted at 15/10/2020 09:51 by katsy DVRG 28/29 bid/offerMWG 27/30 bid/offer Looks like MM don't want anymore trades on MWG. If you want to buy in, get DVRG instead as it's cheaper. If you want to sell wait for the takeover as you'll get more in DVRG (As of today). In other words MWG has been placed on garden leave. |
Posted at 27/9/2020 12:39 by tickboo From lse-I hold a sizeable chunk in what will be DPVG and am more than a little disappointed with the action on Thursday afternoon and Friday. I think the presentation was okay and I liked the fact the wider team was involved although the focus on the breathalyser was too much and detracted from water monitoring which is a game changer and our core competence. Yes the test will be great but it's further down the line and many LF antigen tests are being validated. That said our test needed more time as it's new so needed explaining although the explanation could've been better. The BoD has been in place for a little over 2 years and has taken revenues from £500k in 2018 (only there for 5 months) to £1m 2019 and reaffirmed £4m guidance 2020 and the share from in old money from 0.5p to 3p. The twitter use with hindsight probably attracted traders who have no doubt caused even more volatility so that's a lesson to learn. The lack of media coverage doesn't concern me as we are only beginning live-virus testing so I'd expect a ramp up after a few weeks and hopefully we get updates via RNS. I've no doubt the real-time roll retrofit roll out will occur early next year and given they're existing customers I imagine in order some cash will be up front and the remainder on delivery so decent revenues should come in early next year which should fund production for fresh kits for new customers. If we can't keep up with demand surely with our collaborative business model a partner would be sought. I expect H1 for SKIN to be break even at worst so over £1m in cash and £3m loan facility. MWG had a poor H1 but remember the 48% increase in reagent orders will be mostly shipped this month and revenues realised this half too. H2 will be a lot better and below are some reasons why MWG and SKIN will be stronger together and anyone thinking MWG is a dud is wrong.6 May - Further to the announcement on 30 March 2020 notifying production commencement of the first batch of Modern Water ("MW") reagent, Integumen plc ("Integumen") has commenced s hipping to meet the back-orders and growing demand for water contamination detection bacteria from existing clients. With the increase of water hygiene controls around the world due to the COVID-19 public health crisis, production volume has doubled to a list price value of GBP500,000 per batch. Revenues from sales of reagent produced under the revenue sharing manufacturing agency agreement with Integumen (the "Agreement") will be split 60% / 40% in favour of Modern Water, after costs. The Company expects that that sales of reagent under the Agreement will have a value of at least $1.25m in the current financial year.Integumen and Modern Water have accelerated the integration of their respective water monitoring equipment and AI based contamination detection abilities following increased orders of the Microtox range in Europe and SE Asia, including back fitting Integumen AI based capabilities to the 10 top-of-the-range Microtox CTM units to be shipped to China in the third quarter of 2020 as announced on 23 December 2019. Microtox equipment are built to be modular and expandable. Within this hardware capacity Integumen is configuring its RAWTest [i] AI real-time alert solution to expand the capability of the instruments to detect bacteria, nitrates and phosphates. The roadmap for this integration includes the ability to detect viruses such as SARS-Cov-2. The environmental arm of DEFRA [ii] has confirmed it is looking at wastewater epidemiology and US Centers for Disease Control and Prevention is already monitoring human waste [iii] , the ministry of ecology [iv] in China are mandating the hygiene monitoring of water and wastewater and dormant buildings during the epidemic have built up contaminated water in their pipework [v] Simon Humphrey, CEO of Modern Water commented: "The COVID19 public health crisis may have reached its first wave peak, but the next stage of managing future risk of spreading is the early monitoring of water and wastewater. Demand for equipment and our reagents continue to increase and we are delighted to have access to increased production volumes to allow us expand and the integrated AI development programme that enhances the Microtox value, improving revenue per client from existing equipment."13 May-Modern Water is pleased to announce that, following the collaboration agreement with Ion Exchange (India) Ltd (RNS: 23 December 2019 [i] ), an order for stage one of a two stage project with a total value of c. GBP900,000 project has been received. The estimated net value to Modern Water for stage one is approximately GBP50,000 and for both stages is between c. GBP235,000 and c. GBP270,000. The project consists of an initial pilot plant for the zero-liquid-discharg |
Posted at 14/9/2020 13:58 by gbenson1 The notional value the day of the deal was 4.05p valuing MWG at circa £21m, would you be happy receiving 1 Skin share @ 3-3.5p!! At 3.5p the deal values MWG @ £18.4m which is robbery. I know people say these will be a good fit, share technology, good for each other, however the offer price is way off. If MWG go alone they'll be worth £30m in 6-8 weeks anyway. imho. |
Posted at 08/9/2020 07:55 by tickboo I believe you're missing my point.Okay so MWG might be 5p in 6 months and SKIN 10p. Both PLCs look undervalued and I'd argue SKIN even more so. The MWG and its BoD and need to look after their shareholders and think it a good deal. I hold more MWG than SKIN and am happy with the deal. They've worked closely for 6 months or so and the synergies are obvious and seemingly stronger together.If the real-time solution works for COVID and other pathogens/contaminan |
Posted at 25/8/2020 10:25 by paulcon1 MPYes, of course, massive fan of MWG and their technology, but it seems (to me) they are missing an opportunity with regards any form of marketing. With regards investors the website is very good (better) for products but clumsy and out of date for news/updates - MWG won the technology award in China and basically told no one. Mr Brandon has shown what constant social media presence can achieve with SKIN and of course some of that relates to MWG but it is not always apparent. SKIN's website has a company Newsletter and their was talk of an investor evening, two great ideas for 'getting the info out there' There must be a hangover (from market etc) with MWG after the last 12 months and with a new team, new business model and new direction feel they are missing an opportunity to be bold. Maybe I am bringing some of my personal MWG angst into this, so I apologise and maybe way off the mark, but I believe MWG' is literally a global game changer. GLA and IMHO Please feel free to debate or advise |
Posted at 20/8/2020 10:24 by monkey puzzle Paulcon1 MWG MCAP £12M V SKIN MCAP £38M....that's a massive divergence from previously with skin now 3x MWG value whereas before it was much closer to 1.8 x MWG value. For MWG to restore the previous ration it's share price would need to be @3.2 rather than 2.4. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
